INPLASY202210067 Survival Outcomes and Safety of PD-1/PD-L1 Inhibitors for Unresectable Hepatocellular Carcinoma: Result from Phase III Trials Keywords: PD-1; PD-L1; hepatocellular carcinoma; survival; adverse effects. Download PDF - 202210067 Review Status: Completed and published